IL22 and metabolic dysfunction-associated steatotic liver disease: Interestingly, engineering Lactobacillus reuteri, made by Oh et al., exerted the further therapeutic effect in NAFLD through recombinant Interleukin-22 (IL-22) delivery (Oh et al., 2020).